VAXDIGM
PrivateLast Round
Grant
May 20, 2026
Total Funding Raised
$3.98M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
VAXDIGM operates in Enterprise Software and is based in Seoul. Its latest recorded funding round was a Grant round in May 2026.
VAXDIGM is a biotechnology company that develops innovative vaccines using its proprietary CHAPERNA (Chaperone + RNA) platform technology.
Sector
Enterprise Software
Verticals
Workflow Automation, Project Management
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VAXDIGM Comparables
Compare VAXDIGM with similar companies based on industry and business-model similarity.
No comparables are published for VAXDIGM. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
VAXDIGM Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 20, 2026 | ||||
| Grant | Dec 1, 2025 | ||||
| Series A | Oct 24, 2024 | ||||
| Pre Seed | Aug 1, 2023 | ||||
| Seed | May 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VAXDIGM Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Alternative Investment Asset Management | Series A |
| Infobank Corp | Series A |
| The Invention Lab | Series A |
| LITALCO | Series A |
| New Paradigm Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Raised $1.11M in grant funding.
- Dec 1, 2025
$520K raised in Grant round
For institutional investors. Book with your work email.
VAXDIGM Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VAXDIGM's valuation, stock price, and market status.
Is VAXDIGM a public or private company?
VAXDIGM is a private company.
What is the current stock price of VAXDIGM?
VAXDIGM is a private company, so its shares have no public market price. Caplight tracks VAXDIGM's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VAXDIGM worth (valuation)?
Valuation information for VAXDIGM is not publicly available.
Can I buy VAXDIGM stock?
VAXDIGM shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VAXDIGM's last funding round?
VAXDIGM's most recent funding round was Grant on May 20, 2026.
Who are the main investors in VAXDIGM?
Key investors in VAXDIGM include Korea Alternative Investment Asset Management, Infobank Corp, The Invention Lab, LITALCO, New Paradigm Investment.
Will VAXDIGM IPO soon?
No public IPO plans have been announced for VAXDIGM.
How can I track VAXDIGM secondary market activity?
Caplight tracks bids, offers, and trades in VAXDIGM's shares on secondary markets.